# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001610618-23-000092
Filing Date
2023-09-21
Accepted
2023-09-21 13:24:53
Documents
71
Period of Report
2023-09-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | cdtx-20230921.htm iXBRL | 8-K | 27984
2 | CORPORATE PRESENTATION, DATED SEPTEMBER 21, 2023 | corporatepresentation202.htm | EX-99.1 | 48423
6 | GRAPHIC | corporatepresentation202001.jpg | GRAPHIC | 68385
7 | GRAPHIC | corporatepresentation202002.jpg | GRAPHIC | 155424
8 | GRAPHIC | corporatepresentation202003.jpg | GRAPHIC | 94896
9 | GRAPHIC | corporatepresentation202004.jpg | GRAPHIC | 85607
10 | GRAPHIC | corporatepresentation202005.jpg | GRAPHIC | 91257
11 | GRAPHIC | corporatepresentation202006.jpg | GRAPHIC | 90453
12 | GRAPHIC | corporatepresentation202007.jpg | GRAPHIC | 77305
13 | GRAPHIC | corporatepresentation202008.jpg | GRAPHIC | 63745
14 | GRAPHIC | corporatepresentation202009.jpg | GRAPHIC | 66177
15 | GRAPHIC | corporatepresentation202010.jpg | GRAPHIC | 62098
16 | GRAPHIC | corporatepresentation202011.jpg | GRAPHIC | 70098
17 | GRAPHIC | corporatepresentation202012.jpg | GRAPHIC | 70468
18 | GRAPHIC | corporatepresentation202013.jpg | GRAPHIC | 88369
19 | GRAPHIC | corporatepresentation202014.jpg | GRAPHIC | 80338
20 | GRAPHIC | corporatepresentation202015.jpg | GRAPHIC | 80193
21 | GRAPHIC | corporatepresentation202016.jpg | GRAPHIC | 124966
22 | GRAPHIC | corporatepresentation202017.jpg | GRAPHIC | 92582
23 | GRAPHIC | corporatepresentation202018.jpg | GRAPHIC | 125853
24 | GRAPHIC | corporatepresentation202019.jpg | GRAPHIC | 108292
25 | GRAPHIC | corporatepresentation202020.jpg | GRAPHIC | 75635
26 | GRAPHIC | corporatepresentation202021.jpg | GRAPHIC | 125617
27 | GRAPHIC | corporatepresentation202022.jpg | GRAPHIC | 80983
28 | GRAPHIC | corporatepresentation202023.jpg | GRAPHIC | 80538
29 | GRAPHIC | corporatepresentation202024.jpg | GRAPHIC | 87072
30 | GRAPHIC | corporatepresentation202025.jpg | GRAPHIC | 86351
31 | GRAPHIC | corporatepresentation202026.jpg | GRAPHIC | 80134
32 | GRAPHIC | corporatepresentation202027.jpg | GRAPHIC | 60051
33 | GRAPHIC | corporatepresentation202028.jpg | GRAPHIC | 94546
34 | GRAPHIC | corporatepresentation202029.jpg | GRAPHIC | 79352
35 | GRAPHIC | corporatepresentation202030.jpg | GRAPHIC | 82845
36 | GRAPHIC | corporatepresentation202031.jpg | GRAPHIC | 104685
37 | GRAPHIC | corporatepresentation202032.jpg | GRAPHIC | 123834
38 | GRAPHIC | corporatepresentation202033.jpg | GRAPHIC | 98565
39 | GRAPHIC | corporatepresentation202034.jpg | GRAPHIC | 59839
40 | GRAPHIC | corporatepresentation202035.jpg | GRAPHIC | 85758
41 | GRAPHIC | corporatepresentation202036.jpg | GRAPHIC | 92820
42 | GRAPHIC | corporatepresentation202037.jpg | GRAPHIC | 68126
43 | GRAPHIC | corporatepresentation202038.jpg | GRAPHIC | 94677
44 | GRAPHIC | corporatepresentation202039.jpg | GRAPHIC | 54678
45 | GRAPHIC | corporatepresentation202040.jpg | GRAPHIC | 94005
46 | GRAPHIC | corporatepresentation202041.jpg | GRAPHIC | 104570
47 | GRAPHIC | corporatepresentation202042.jpg | GRAPHIC | 91264
48 | GRAPHIC | corporatepresentation202043.jpg | GRAPHIC | 81840
49 | GRAPHIC | corporatepresentation202044.jpg | GRAPHIC | 97784
50 | GRAPHIC | corporatepresentation202045.jpg | GRAPHIC | 105528
51 | GRAPHIC | corporatepresentation202046.jpg | GRAPHIC | 84478
52 | GRAPHIC | corporatepresentation202047.jpg | GRAPHIC | 89438
53 | GRAPHIC | corporatepresentation202048.jpg | GRAPHIC | 81749
54 | GRAPHIC | corporatepresentation202049.jpg | GRAPHIC | 68444
55 | GRAPHIC | corporatepresentation202050.jpg | GRAPHIC | 65547
56 | GRAPHIC | corporatepresentation202051.jpg | GRAPHIC | 68375
57 | GRAPHIC | corporatepresentation202052.jpg | GRAPHIC | 103431
58 | GRAPHIC | corporatepresentation202053.jpg | GRAPHIC | 98214
59 | GRAPHIC | corporatepresentation202054.jpg | GRAPHIC | 80117
60 | GRAPHIC | corporatepresentation202055.jpg | GRAPHIC | 62723
61 | GRAPHIC | corporatepresentation202056.jpg | GRAPHIC | 89962
62 | GRAPHIC | corporatepresentation202057.jpg | GRAPHIC | 157672
63 | GRAPHIC | corporatepresentation202058.jpg | GRAPHIC | 125678
| Complete submission text file | 0001610618-23-000092.txt |  | 7340066

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cdtx-20230921.xsd | EX-101.SCH | 1899
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cdtx-20230921_lab.xml | EX-101.LAB | 25156
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cdtx-20230921_pre.xml | EX-101.PRE | 13048
65 | EXTRACTED XBRL INSTANCE DOCUMENT | cdtx-20230921_htm.xml | XML | 2829

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 231268656
SIC: 2836 Biological Products, (No Diagnostic Substances)